Advertisement

Payer

Optum is tracking four drugs for recent or potential mid-2021 FDA approval, according to the payer's latest Drug Pipeline Insights Report.

Advertisement

Insurers around the country are gradually reinstating coronavirus-related copays and deductibles, and despite public speculation that payers are looking to cash in, analysts say it could play a key role in encouraging vaccination. 

Advertisement